The Cell Therapy stream explores the critical challenges facing the manufacture, analysis and quality of cell-based therapies. Topics include product and process characterization, CMC strategies, autologous and allogeneic manufacturing strategies, automation, scale-up and supply of CAR Ts and next-generation cell therapies such as NK cells, TILs, iPSCs and TCR-based therapies. 

Conferences Include:

Keynote and Featured Presentations

Potency Assay Development for Cell-Based Therapies
Therese Choquette, PhD, Director, Analytics, Tigen


Method Development Strategy for Release Methods
Akshata Ijantkar, Senior Scientist, Analytical Development, Bristol Myers Squibb Co.


CMC Challenges with CAR T Manufacturing: Reimagining Process and Product Control Strategy
Sunitha Lakshminarayanan, Head & Executive Director, Cell Therapy Global Process Engineering, Bristol Myers Squibb Co.


AI, Digitalization in Cell Therapy Manufacturing
Krishnendu Roy, PhD, Robert A. Milton Chair & Director, Center for Cell Manufacturing & Center for Immuno-Engineering, Georgia Institute of Technology


Current Challenges in Cell Therapy CMC
Current Challenges in Cell Therapy CMC Bruce S. Thompson, PhD, Vice President and Technical Lead, Cell Therapy, National Resilience, Inc.